Steven N.Geise (Steve)

Partner-in-Charge San Diego

サンディエゴ + 1.858.314.1170

Steve Geise is a nationally recognized first-chair trial lawyer who focuses on representing companies in high-stakes cases involving millions of dollars in potential damages.

Steve has tried dozens of product liability cases and has won defense verdicts coast to coast in federal and state courts. In 2017, he led a team that secured a defense verdict in a Bay Area trial for R.J. Reynolds that earned the Daily Journal's "Top Defense Verdict Award." His continued success on behalf of the Firm's clients led Best Lawyers in America to recognize Steve as "Lawyer of the Year" for product liability litigation/defendants in San Diego in 2020.

Steve represents manufacturers of medical devices, pharmaceuticals, opioids, and other consumer goods in all phases of individual and class action litigation and is currently advising clients on litigation risks stemming from business disruptions caused by the COVID-19 pandemic. Because of his experience in jury trials, he frequently collaborates with trial teams in product liability, intellectual property, and general litigation cases on trial themes, presentation, and strategy. Notably, Steve was a member of the trial team that achieved a $2.54 billion patent infringement verdict for Idenix Pharmaceuticals (a subsidiary of Merck & Co.) over medicines to treat patients with hepatitis C virus (HCV) infection.

Steve is Partner-in-Charge of the San Diego Office and also serves as the office's head of litigation and loss prevention partner. He is a Master in the Welsh Inn of Court and a former Lawyer Representative to the Southern District of California (2015-2019).

担当案件

  • R.J. Reynolds wins complete defense verdict in Ellis "Engle progeny" lawsuitOn December 7, 2018, following ten days of trial, a jury in Tampa, Florida returned a defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a wrongful death action.
  • Idenix wins $2.54 billion jury verdict in Gilead patent dispute involving hepatitis C drugsAfter a nine day trial and less than two hours of jury deliberation, Jones Day, on behalf of Idenix Pharmaceuticals LLC (a subsidiary of Merck & Co.), won the largest patent infringement verdict in U.S. history to date, involving a multi-billion dollar patent dispute with Gilead Sciences Inc. over sofosbuvir, the active ingredient in Gilead’s hepatitis C drugs Sovaldi® and Harvoni®.
  • R.J. Reynolds wins Bay Area jury verdict in Pooshs trialOn February 8, 2016, following three weeks of trial and nearly 12 years of litigation, a federal jury in Oakland, California took less than 90 minutes to return a defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a personal injury action.
  • R.J. Reynolds wins jury verdict in Ellis "Engle progeny" lawsuitOn September 11, 2014, following three weeks of trial and less than four hours of deliberation, a jury in Jacksonville, Florida returned a verdict in favor of Jones Day client R.J. Reynolds Tobacco Company ("R.J. Reynolds") in a wrongful death action, finding that the decedent-smoker was not a member of the Engle class.
  • Jones Day San Diego reaches settlement of civil rights claimsPursuant to the Southern District of California’s Plan for the Representation of Pro Se Litigants in Civil Cases, Jones Day San Diego was selected for pro bono representation of Raynard Vallery, the plaintiff in a civil rights action under 42 U.S.C. § 1983.
  • R.J. Reynolds obtains dismissal of In re Tobacco II Cases class action in CaliforniaJones Day represented R.J. Reynolds Tobacco Company in this multi billion dollar, statewide smokers' class action against the major tobacco companies.
  • R.J. Reynolds wins jury verdict in Pickett ''Engle progeny'' lawsuitJones Day obtained another win on behalf of R.J. Reynolds Tobacco Company in Pickett v. R.J. Reynolds, the third “Engle progeny” lawsuit tried to verdict in federal court.
  • Celgene secures nonsuit in Texas pain pump litigationJones Day defended Celgene Corporation in a personal injury product liability action brought against pharmaceutical and medical device manufacturers.
  • Celgene obtains dismissal of pain pump case in PhiladelphiaJones Day represented Celgene Corporation in this personal injury lawsuit alleging chondrolysis of the shoulder following the administration of bupivacaine and marcaine via a pain pump.
  • Celgene obtains dismissal in Washington product liability actionJones Day, on behalf of Celgene Corporation, obtained a dismissal of a product liability suit against a host of drug and medical device manufacturers stemming from alleged heparin-induced thrombocytopenia or "HIT".
  • R.J. Reynolds defeats wrongful death litigationJones Day defended R.J. Reynolds Tobacco Co. in a wrongful death trial brought against four cigarette manufacturers seeking to recover for the decedent's death from lung cancer following decades of smoking.
  • R.J. Reynolds wins jury verdict in Vasko ''Engle progeny'' lawsuitJones Day successfully represented R.J. Reynolds Tobacco Company in the latest "Engle progeny" lawsuit to reach a jury verdict, marking the continuation of a string of seven defense verdicts in the past two months.
  • Yamaha successfully defends nationwide litigation of product liability cases and claims involving the Rhino side-by-side ("SxS") vehicleJones Day leads Yamaha's defense of Rhino cases and claims pending in the United States.
  • Novo Industries defends child strangulation case involving window blindsJones Day represents Novo Industries in a child strangulation case involving window blinds.
  • R.J. Reynolds obtains summary judgment in 40-count wrongful death actionJones Day represented R.J. Reynolds Tobacco Company in a 40-count survival and wrongful death action alleging that the decedent's lengthy smoking history caused his lung cancer and, ultimately, his death.
  • R.J. Reynolds obtains stipulated dismissal with prejudice of smoking and health case in the District Court of the Navajo NationJones Day, on behalf of R.J. Reynolds Tobacco Company, obtained a stipulated dismissal with prejudice of a smoking-and-health case brought in the District Court of the Navajo Nation after filing an aggressive motion to dismiss based in part on the tribal court's lack of subject matter jurisdiction.
  • R.J. Reynolds wins dismissal of smoking and health action filed in the District of ArizonaJones Day represented R.J. Reynolds Tobacco Company in this smoking and health action filed in the District of Arizona.
  • Experian defends nationwide class action involving credit reportingJones Day defended Experian in a proposed nationwide class action involving a legal issue of first impression: whether the Fair Credit Reporting Act requires credit reporting agencies to obtain and report credit information from credit grantors who do not choose to submit such credit information.
  • R.J. Reynolds wins jury verdict in first smoking and health case tried in ManhattanIn the first smoking and health case to be tried in Manhattan, Jones Day defended R.J. Reynolds Tobacco Company against claims that the plaintiff's cancer was caused by her cigarette smoking.
  • セミナー・講演

    • June 2011
      Class Action Litigation Strategy 2011 -- Current Trends and Hot Topics, Association of Corporate Counsel, San Diego Chapter
    • January 2010
      Handling a Mistake with Benefit of Hindsight
    • January 2010
      Ethical Considerations for In-House Counsel
    • August 2009
      Ethical Considerations for In-House Counsel
    • January 2006
      Winning Legal Strategies for Product Liability 2006
    • February 2004
      Personal Injury Discovery in a Private World
    • San Antonio, Texas
      Emerging Issues and Strategies in Tobacco Litigation
    *We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.